View in EDS

Authors’ Reply to Pande et al. Comment on 'Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder'

Saved in:
Bibliographic Details
Title: Authors’ Reply to Pande et al. Comment on 'Extended-Release Viloxazine Compared to Atomoxetine for Attention Deficit Hyperactivity Disorder'
Authors: Maxwell Z. Price, Richard L. Price
Source: CNS Drugs
Publisher Information: Springer Science and Business Media LLC, 2023.
Publication Year: 2023
Subject Terms: Letter to the Editor
Document Type: Article
Other literature type
Language: English
ISSN: 1179-1934
1172-7047
DOI: 10.1007/s40263-023-01035-2
Access URL: https://pubmed.ncbi.nlm.nih.gov/37656357
Rights: CC BY NC
URL: http://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (http://creativecommons.org/licenses/by-nc/4.0/) .
Accession Number: edsair.doi.dedup.....b132f34b1b1075b9f38d302b1745b5e7
Database: OpenAIRE
Description
ISSN:11791934
11727047
DOI:10.1007/s40263-023-01035-2